MSMB Capital Offers to Acquire Amag Pharmaceuticals (AMAG) for $18/Share

August 3, 2011 6:49 AM EDT
MSMB Capital Management made a proposal to the Board of Directors of Amag Pharmaceuticals Inc. (NASDAQ: AMAG) to acquire all of the outstanding shares of common stock of Amag for $18 per share in cash or an aggregate of $378 million.

This proposal represents an approximate 25% premium above the closing price of Amag stock of $14.39 on August 2, 2011.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Hot M&A, Mergers and Acquisitions, Private Equity

Add Your Comment